Luuhõrenemine

Luuhõrenemine, also known as osteoporosis, is a medical condition characterized by a decrease in bone density and mass, leading to weakened bones and an increased risk of fractures. It is a progressive disease that often develops over many years without noticeable symptoms. As bone tissue deteriorates, bones become more fragile and susceptible to breaking, particularly in the hip, spine, and wrist.

Several factors can contribute to the development of luuhõrenemine. Age is a significant factor, as bone density naturally decreases with advancing years. Hormonal changes, especially in women after menopause due to a drop in estrogen levels, play a crucial role. Genetics, a sedentary lifestyle, poor nutrition, especially insufficient intake of calcium and vitamin D, and certain medical conditions or medications can also increase the risk.

The diagnosis of luuhõrenemine is typically made through a bone mineral density test, commonly known as a DEXA scan. This non-invasive procedure measures the calcium content in bones and compares it to that of a healthy young adult. Treatment strategies aim to slow bone loss, increase bone density, and reduce the risk of fractures. These may include lifestyle modifications such as weight-bearing exercises and dietary adjustments, as well as medication to stimulate bone formation or inhibit bone breakdown. Early detection and intervention are key to managing luuhõrenemine effectively and maintaining bone health throughout life.